Persistent impaired glucose metabolism in a zebrafish hyperglycemia model

Comparative Biochemistry and Physiology Part - B: Biochemistry and Molecular Biology

Volumn 171, Issue 1, 2014, Pages 58-65

  Capiotti, Katiucia Marques ^a,b   Antonioli, Régis ^a,b   Kist, Luiza Wilges ^a,b   Bogo, Maurício Reis ^a,b   Bonan, Carla Denise ^a,b   Da Silva, Rosane Souza ^a,b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

Author keywords

Diabetes mellitus; Glucose; Insulin receptor; Metabolism; Zebrafish

Indexed keywords

GLIMEPIRIDE; GLUCOSE; GLYCOSYLATED PROTEIN; HUMAN INSULIN; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; METFORMIN; ANTIDIABETIC AGENT; EYE PROTEIN; SULFONYLUREA DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN RESPONSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZEBRA FISH; ANIMAL; DISEASE MODEL; GLYCOSYLATION; METABOLISM; SKELETAL MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; EYE PROTEINS; GLUCOSE; GLYCOSYLATION; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; MUSCLE, SKELETAL; RECEPTOR, INSULIN; SULFONYLUREA COMPOUNDS; ZEBRAFISH;

EID: 84899883581     PISSN: 10964959     EISSN: 18791107     Source Type: Journal    
DOI: 10.1016/j.cbpb.2014.03.005     Document Type: Article

References (47)

1. Alvarez Y., Chen K., Reynolds A.L., Waghorne N., O'Connor J.J., Kennedy B.N. Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Dis. Model. Mech. 2010, 3-4:236-245.
2. Armbruster D.A. Fructosamine: structure, analysis, and clinical usefulness. Clin. Chem. 1987, 33:2153-2163.
3. Asaoka Y., Terai S., Sakaida I., Nishina H. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis. Model. Mech. 2013, 6:905-914.
4. Association American Diabetes Standards of medical care in diabetes-2013. Diabetes Care 2013, 36:S11-S66.
5. Bailey C.J., Turner R.C. Metformin. N. Engl. J. Med. 1996, 334:574-579.
6. Bogé G., Péres G. Chloride requirements of sodium cotransporter systems. Comp. Physiol. 1990, 186-215.
7. Briscoe V.J., Griffith M.L., Davis S.N. The role of glimepiride in the treatment of type 2 diabetes mellitus. Expert. Opin. Drug Metab. Toxicol. 2010, 6:225-235.
8. Campbell R.K. Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus. Ann. Pharmacother. 1998, 32:1044-1052.
9. Eames S.C., Philipson L.H., Prince V.E., Kinkel M.D. Blood sugar measurement in zebrafish reveals dynamics of glucose homeostasis. Zebrafish 2010, 7:205-213.
10. Elo B., Villano C.M., Govorko D., White L.A. Larval zebrafish as a model for glucose metabolism: expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds. J. Mol. Endocrinol. 2007, 38:433-440.
11. Ferraris R.P., Ahearn G.A. Sugar and aminoacid transport in fish intestine. Comp. Biochem. Physiol. 1984, 3:397-413.
12. Gleeson M., Connaughton V., Arneson L.S. Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol. 2007, 44:150-163.
13. Gunton J.E., Delhanty P.J., Takahashi S., Baxter R.C. Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2. J. Clin. Endocrinol. Metab. 2003, 88:1323-1332.
14. Hällsten K., Virtanen K.A., Lon̈nqvist F. Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed Type 2 diabetes. Diabetes 2002, 51:3479-3484.
15. Harris M., Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance. International Textbook of Diabetes Mellitus 1997, 9-23. John Wiley and Sons Ltd., Chichester. Second edition. K. Alberti, P. Zimmet, R. Defronzo (Eds.).
16. International Diabetes Federation (IDF) Diabetes Atlas 2012, Russels, Belgium. 5th edition.
17. Juraschek S.P., Steffes M.W., Miller E.R., Selvin E. Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care 2012, 35:2265-2270.
18. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., Neifing J.L., Ward W.K., Beard J.C., Palmer J.P., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993, 42:1663-1672.
19. Lee S.-Y., Chen Y.-C., Tsai I.-C., Yen C.-J., Chueh S.-N., et al. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. PLoS ONE 2013, 8:e57762.
20. Maddison L.A., Chen W. Nutrient excess stimulates β-cell neogenesis in zebrafish. Diabetes 2012, 61:2517-2524.
21. McIntyre H.D., Ma A., Bird D.M., Paterson C.A., Ravenscroft P.J., Cameron D.P. Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus. Aust. N. Z. J. Med. 1991, 21:714-719.
22. Moyle P., Cech J. Fishes: An Introduction to Ichthyology 2000, Prentice Hall, Upper Saddle River, USA.
23. Muller G., Geisen K. Characterization of the molecular mode of action of the sulphonylurea, glimepiride at adipocytes. Horm. Metab. Res. 1996, 28:469-487.
24. Muller G., Wied S. The sulphonylurea drug, glimepiride, stimulates glucose transport, glucose transport translocation, and dephosphorylation in insulin-resistance rat adipocytes in vitro. Diabetes 1994, 5:985-996.
25. Muller G., Satoh Y., Geisen K. Extrapancreatic effects of sulphonylureas - a comparison between glimiperide and conventional sulphonylureas. Diabetes Res. Clin. Pract. 1995, 28:S115-S137.
26. Nathan D.M., Buse J.B., Davidson M.B., Ferranninni E., Holman R.R., Sherwin R., Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009, 32:193-203.
27. Nery L.R., Rodrigues M.M., Rosemberg D.B., Bogo M.R., De Farias C.B., Abujamra A.L., Schwartsmann G., Roesler R., Vianna M.R. Regulation of E-cadherin expression by growth factor receptors in cancer cells. J. Surg. Oncol. 2011, 104:220-221.
28. Oggier D.M., Weisbrod C.J., Stoller A.M., Zenker A.K., Fent K. Effects of diazepam on gene expression and link to physiological effects in different life stages in zebrafish Danio rerio. Environ. Sci. Technol. 2010, 44:7685-7691.
29. Oka T., Nishimura Y., Zang L., Hirano M., Shimada Y., Wang Z., Umemoto N., Kuroyanagi J., Nishimura N., Tanaka T. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010, 21:10-21.
30. Olsen A.S., Sarras M.P., Intine R.V. Limb regeneration is impaired in an adult zebrafish model of diabetes mellitus. Wound Repair Regen. 2010, 18:532-542.
31. Pedroso G.L., Hammes T.O., Escobar T.D., Fracasso L.B., Forgiarini L.F., da Silveira T.R. Blood collection for biochemical analysis in adult zebrafish. J. Vis. Exp. 2012, 26:e3865.
32. Pessin J.E., Saltiel A.R. Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 2000, 106:165-169.
33. Phelps H.A., Runft D.L., Neely M.N. Adult Zebrafish Model of Streptococcal Infection. Current Protocols in Microbiology 2009, 13. 9D.1.1-9D.1.27.
34. Polakof S., Comte B. Glucose-induced insulin secretion: nutritional prevention and novel avenues for therapy. Adv. Exp. Med. Biol. 2012, 771:319-339.
35. Polakof S., Moon W., Aguirre P., Skiba-Cassy S., Panserat S. Glucose homeostasis in rainbow trout fed a high-carbohydrate diet: metformin and insulin interact in a tissue-dependent manner. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R166-R174.
36. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., Montminy M., Cantley L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
37. Siccardi A.J., Garris H.W., Jones W.T., Moseley D.B., D'Abramo L.R., Watts S.A. Growth and survival of zebrafish (Danio rerio) fed different commercial and laboratory diets. Zebrafish 2009, 3:275-280.
38. a Edição.
39. Stewart A.M., Nguyen M., Wong K., Poudel M.K., Kalueff A.V. Developing zebrafish models of autism spectrum disorder (ASD). Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 50:27-36.
40. Stumvoll M., Nurjhan N., Perriello G., Dailey G., Gerich J.E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 1995, 31:550-554.
41. Tang R., Dodd A., Lai D., Mcnabb W.C., Love D.R. Validation of zebrafish (Danio rerio) reference genes for quantitative real-time RT-PCR normalization. Acta Biochim. Biophys. Sin. 2007, 39:384-390.
42. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
43. Toyoshima Y., Monson C., Duan C., Wu Y., Gao C., Yakar S., Sadler K.C., LeRoith D. The role of insulin receptor signaling in zebrafish embryogenesis. Endocrinology 2008, 149:5996-6005.
44. Tseng Y.C., Chen R.D., Lee J.R., Liu S.T., Lee S.J., Hwang P.P. Specific expression and regulation of glucose transporters in zebrafish ionocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R275-R290.
45. Whitehead J.P., Clark S.F., Urso B., James D.E. Signaling through the insulin receptor. Curr. Opin. Cell Biol. 2000, 12:222-228.
46. Yang J., Holman G.D. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology 2006, 147:2728-2736.
47. Ye J. Mechanisms of insulin resistance in obesity. Front. Med. 2013, 7:14-24.